Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:48:28.209Z.
Calculation as of: 2026-10-06T21:48:28.209Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ca1169366ca7231828fa2f87c24c2e776dca628497ffd55dbb7a20e210c1aea1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Tyra Biosciences, Inc.
Market Cap
$1.21B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.20B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.22B
Free Cash Flow Yield
4.13%
TTM Avg
3.70%
3Y Avg
3.54%
5Y Avg
2.76%
Market Cap
$1.23B
Free Cash Flow Yield
4.05%
TTM Avg
2.05%
3Y Avg
1.76%
5Y Avg
1.76%
Market Cap
$1.18B
Free Cash Flow Yield
N/A
TTM Avg
1.83%
3Y Avg
1.56%
5Y Avg
1.56%
Market Cap
$1.24B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Free Cash Flow Yield
N/A
TTM Avg
11.05%
3Y Avg
11.05%
5Y Avg
11.05%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | $1.21B | N/A | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.21B | N/A | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 4.13% | 3.70% | 3.54% | 2.76% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 4.05% | 2.05% | 1.76% | 1.76% |
| MannKind Corporation (MNKD)vs › | $1.18B | N/A | 1.83% | 1.56% | 1.56% |
| Omada Health (OMDA)vs › | $1.23B | 1.63% | 1.62% | 1.62% | 1.62% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.14B | N/A | 11.05% | 11.05% | 11.05% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 13.38% | 12.18% | 9.49% | 7.36% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
